PCR
ActiveSummary
The computed 12-month bankruptcy probability of PCR is 1.5% (moderate). The annual accounts of PCR for financial year 2025 show a net loss of 51% of the equity at the start of that year. The 2025 annual accounts show equity of €14,802 and a net result of -€15,397. Its solvency ranks better than 28% of 1,816 sector peers (NACE 77, financial year 2025). The company has been active since 2023 and the Belgian Official Gazette contains no insolvency or warning signals.
Directors
Directors
No directors read yet: 1 of 2 Gazette acts processed. See the directors and other office holders in the KBO →
Owners and capital
Owners
No owners or capital events in the accounts and acts we read.